Brief: Crescita Signs Exclusive 8-Country Licensing Agreement With Egis Pharmaceuticals For Pliaglis
13/12/2021 13:44
Dec 13 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* CRESCITA SIGNS EXCLUSIVE 8-COUNTRY LICENSING AGREEMENT
WITH EGIS
PHARMACEUTICALS FOR PLIAGLIS®
Source text for Eikon: ID:nBw2mdG7a
Further company coverage: CTX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium